Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors

Journal of Clinical Ultrasound

Volumn 28, Issue 1, 2000, Pages 1-13

  Strobel, Deike ^a   Krodel, Udo ^a   Martus, Peter ^a   Hahn, Eckhart Georg ^a   Becker, Dirk ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Color Doppler ultrasonography; Liver tumors; Ultrasonography; Ultrasound contrast agents

Indexed keywords

SHU 508;

ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; HUMAN; LIVER CELL CARCINOMA; LIVER CYST; LIVER HEMANGIOMA; LIVER HYPERPLASIA; LIVER METASTASIS; MAJOR CLINICAL STUDY;

CONFIDENCE INTERVALS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; EVALUATION STUDIES; FEMALE; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0033960944     PISSN: 00912751     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0096(200001)28:1<1::AID-JCU1>3.0.CO;2-J     Document Type: Article

References (31)

1. Taylor KJW, Ramos I, Morse SS, et al. Focal liver masses: differential diagnosis with pulsed Doppler US. Radiology 1987;164:643.
2. Merritt CRB. Doppler color flow imaging. J Clin Ultrasound 1987;15:591.
3. Ohnishi K, Nomura F. Ultrasonic Doppler studies of hepatocellular carcinoma and comparison with other hepatic focal lesions. Gastroenterology 1989; 97:1489.
4. Tanaka S, Kitamura T, Fujita M, et al. Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol 1990;154:509.
5. Shimamoto K, Sakuma S, Ishigaki T, et al. Intratumoral blood flow: evaluation with color Doppler echography. Radiology 1987;165:683.
6. Tanaka S, Kitamra T, Fujita M, et al. Small hepatocellular carcinomas: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging. Radiology 1992;182:161.
7. Nino-Murcia M, Ralls PW, Jeffrey RB, et al. Color Doppler flow characterization of focal liver lesions. AJR Am J Roentgenol 1992;159:1195.
8. Kudo M, Tomita S, Tochio H, et al. Sonographic angiography: value in differential diagnosis of hepatic tumors. AJR Am J Roentgenol 1992;158:65.
9. Numata K, Tanaka K, Mitsui L, et al. Flow characteristics of hepatic tumours at colour Doppler sonography: correlation with arteriographic findings. AJR Am J Roentgenol 1993;160:515.
10. Becker D, Günter E, Hahn EG, et al. Imaging of tumor vascularization of hepatocellular carcinoma via ultrasound angiography. Ultraschall Med 1995; 16:109.
11. Lencioni R, Masalchi M, Caramella M, et al. Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging. Abdom Imaging 1996;21:41.
12. Goldberg BB, Hilpert PL, Burns PN, et al. Hepatic tumors: signal enhancement at Doppler US after intravenous injection of a contrast agent. Radiology 1990;177:713.
13. Goldberg BB, Liu J, Burns PN, et al. Galactose-based intravenous sonographic contrast agent: experimental studies. J Ultrasound Med 1993;12: 463.
14. Behan M, O'Connell D, Mattrey R, et al. Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results. AJR Am J Roentgenol 1993;160:399.
15. Burns PN. Ultrasound contrast agents in radiological diagnosis. Radiol Med (Torino) 1994;87(Suppl 1):71.
16. Schlief R. Diagnostic potential of intravenous contrast enhancement in various areas of cardiovascular Doppler ultrasound. Efficacy results of a multinational clinical trial with galactose-based agent SH U 508A. Echocardiography: A Journal of Cardiovascular Ultrasound and Allied Technology 1993;10:665.
17. Rao JNK, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics 1992;48: 577.
18. Cosgrove D. Ultrasound contrast enhancement of tumors. Clin Radiol 1996;51:44.
19. Leen E, McArdle CS. Ultrasound contrast agents in liver imaging. Clin Radiol 1996;51:35.
20. Schlief R. Developments in echo-enhancing agents. Clin Radiol 1996;51:5.
21. Angeli E, Carpanelli R, Crespi G, et al. Efficacia del SH U 508A (Levovist) nella valutione con color-Doppler delia vascolarizzazione dell épatocarcinoma. Radiol Med (Torino) 1994;87(Suppl 1):24.
22. Maresca G, Barbaro B, Summaria V, et al. Efficacia del SH U 508A (Levovist) nella diagnosi differenziale con eco-color-Doppler delle lesioni focali epatiche. Radiol Med (Torino) 1994;87(Suppl 1)-41.
23. Ernst H, Hahn EG, Balzer T, et al. Color Doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. J Clin Ultrasound 1996;24:31.
24. Leen E, Angerson WJ, Warren HW, et al. Improved sensitivity of colour Doppler flow imaging of colorectal hepatic metastases using galactose microparticles: a preliminary report. Br J Surg 1994;81: 252.
25. Tanaka S, Kitamra T, Yoshioka F, et al. Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma. Ultrasound Med Biol 1995;21:157.
26. Lin ZY, Wang LY, Wang JH, et al. Clinical utility of color Doppler sonography in the differentiation of hepatocellular carcinoma from metastases and hemangioma. J Ultrasound Med 1997;16:51.
27. Choi BI, Kim TK, Han JK, et al. Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors. Radiology 1996;200:55.
28. Lee MG, Auh YH, Cho KS, et al. Color Doppler flow imaging of hepatocellular carcinomas. Comparison with metastatic tumors and hemangiomas by three-step grading for color hues. Clin Imaging 1996;20:199.
29. Golli M, Mathieu D, Anglade MC, et al. Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imaging. Radiology 1993;187:113.
30. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975;59:995.
31. Golli M, Van Nhieu JT, Mathieu D, et al. Hepatocellular adenoma: color Doppler US and pathologic correlations. Radiology 1994;190:741.